1079.20
1.98%
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
Cohance Lifesciences Ltd. has gained 67.54% in the last 1 Year
More from Cohance Lifesciences Ltd.
Recommended